Hansa Biopharma reports positive efficacy and safety results from Idefirix European post authorizat

Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Prese

U.S. IPO Weekly Recap: Trio Of Sizable Listings Underwhelm To Close Out January

OptiNose (OPTN) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimat

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

OptiNose (OPTN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimat

The average of price targets set by Wall Street analysts indicates a potential upside of 143.1% in O

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

OptiNose stock surges 53% as it is set to be acquired by Paratek for $330 million, adding chronic rh

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inves

NEW YORK , March 20, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"),

20 Mar

MONSEY, N.Y., March 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigatin

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Optinose (NASDAQ:OPTN) for possible brea

YARDLEY, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company fo

Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing th

Preliminary XHANCE prescription growth rate from third quarter to fourth quarter 2024 estimated to b

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical comp

YARDLEY, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company foc

OptiNose, Inc. (NASDAQ:OPTN ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

  During Wednesday's session, 212 companies made new 52-week lows.

  On Monday, 85 stocks hit new 52-week lows.

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings

Companies Reporting Before The Bell • Cohen & Co (AMEX:COHN) is likely to report earnings for i

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on

 Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the com

  Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earn

  Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnin

  Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stoc

Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Monday

Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018

Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018

Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018

Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018

Stocks Which Set New 52-Week Low Yesterday, October 2nd

Stocks Which Set New 52-Week Low Yesterday, October 1st

58 Biggest Movers From Yesterday